However, it is notable that the most characteristic TP53-associated cancers, particularly early-onset breast cancer and sarcomas, remained significantly associated with reduced penetrance variants, although with lower level of enrichment than for the group with standard pathogenic variants. The gene discussed is TP53; the disease is breast cancer.